Adverse events after drug infusion
. | Treatment . | . | . | ||
|---|---|---|---|---|---|
| . | Group 1 . | Group 2 . | . | ||
| Symptoms . | DDAVP; n . | Eptifibatide and l-aspirin; n . | Eptifibatide, l-aspirin, and DDAVP;n . | ||
| Headache | 4 | 2 | 4 | ||
| Hypotension* | 3 (systemic) | 3 (systemic) | 5 (systemic) | ||
| 8 (diastolic) | 5 (diastolic) | 7 (diastolic) | |||
| Facial flush | 1 | 0 | 2 | ||
| Nausea | 1 | 0 | 0 | ||
| Thrombocytopenia† | 0 | 0 | 0 | ||
. | Treatment . | . | . | ||
|---|---|---|---|---|---|
| . | Group 1 . | Group 2 . | . | ||
| Symptoms . | DDAVP; n . | Eptifibatide and l-aspirin; n . | Eptifibatide, l-aspirin, and DDAVP;n . | ||
| Headache | 4 | 2 | 4 | ||
| Hypotension* | 3 (systemic) | 3 (systemic) | 5 (systemic) | ||
| 8 (diastolic) | 5 (diastolic) | 7 (diastolic) | |||
| Facial flush | 1 | 0 | 2 | ||
| Nausea | 1 | 0 | 0 | ||
| Thrombocytopenia† | 0 | 0 | 0 | ||